Featured Innovations
Find Your MIM Solution at SNMMI
MIM Theranostics Solutions
Unlock the Opportunities of Theranostics
Efficiency at Every Step of the Patient Care Journey
Implement personalized care on a single, comprehensive platform. From patient selection to therapy response monitoring to dosimetry and communicating outcomes, MIM Theranostics Solutions help make the promise of precision with Theranostics attainable.
- LesionID™ Pro: Aids treatment decision-making and response monitoring
- MIM SurePlan™ MRT: Single time-point and multi-time-point dosimetry
- MIM Encore™: Comprehensive single platform for post-processing, reading, analysis, and collaboration
MIM Molecular Imaging Solutions
Boost Clinical Efficiency
Flexible Workflow Automation and Standardization
Handle increasing caseloads with an intuitive vendor-neutral platform for viewing, advanced quantitation, collaboration, and data management.
- MIM Encore: Comprehensive single platform for post-processing, reading, analysis, and collaboration
- MIMneuro™: Brain imaging and quantitative analysis with multi-tracer support
- MIM SurePlan™ LiverY90: Time-saving tools for liver and tumor segmentation, deformable registration, and posttreatment dosimetry using Y90-PET and Bremsstrahlung SPECT
Say Hello
in Booth 1023
Participate in live demos and talk with MIM specialists to find a solution that works for you.
Breakfast Satellite Symposium
Imaging Biomarkers
in the Era of Theranostics
Tuesday, June 24 | 6:45 - 7:45 a.m. CT
Room R02-R03, Level 2
Overview
Imaging of Theranostic agents promises to answer key clinical questions: Is my patient a good candidate for the therapy? Is my patient likely to respond or experience radiation-induced toxicity? Is my patient responding to treatment so far? In the MIM Software Satellite Symposium at SNMMI, learn about how total tumor burden quantification and dosimetry can be practically incorporated into your clinical routine and enable you to make more informed decisions for your patients.
Breakfast provided!
Speakers
Julia Brosch-Lenz, PhD
Lead Medical Physicist - Radiopharmaceutical Therapy Research | Institute of Nuclear Medicine
Danny Mena Cortes, MD, MBA
Chief of Nuclear Medicine Dept. | Oncología San José, México
More SNMMI Events
Hear from Industry Experts and Connect with Colleages
Saturday, June 21
12:45 - 1:45 p.m. CT | Room 357
Hands-on Dosimetry Training Workshop
Kick off the SNMMI Annual Meeting with an educational workshop on processing dosimetry with MIM SurePlan MRT. Physicians, physicists, and technologists who are registered for the annual meeting are all invited to join. The session will include a discussion on total tumor burden segmentation with LesionID Pro.
MIM Software, a GE HealthCare Company
Register NowSunday, June 22
6:45 - 7:45 a.m. CT
Advancing cardiac PET accessibility: Implementing shared cardiac PET services with Flyrcado™ (flurpiridaz F 18) injection
Mouaz Al-Mallah, MD – Houston Methodist
James Case, PhD – Cardiovascular Imaging Technologies
Gina Herrera-Lopez, CNMT, RT(CT) – Baptist Health South Florida
Implementing a shared Myocardial Perfusion Imaging (MPI) PET/CT program, healthcare institutions can position themselves at the forefront of advanced cardiac imaging while optimizing resource utilization. Previously, however, implementing a shared program was hindered by the availability of cardiac PET tracers requiring an on-site cyclotron or generator. The introduction of Flyrcado (flurpiridaz F 18) injection now provides accessibility of a unit dose cardiac PET tracer supplied from a local CMO allowing healthcare institutions to consider implementing a shared cardiac PET program without a large upfront financial commitment. This session will provide an overview of the practical considerations and clinical value of implementing a shared cardiac PET/CT MPI program with Flyrcado.
GE HealthCare
Monday, June 23
6:45 - 7:45 a.m. CT
Advancing PSMA Theranostics: Integrating Digital Imaging and AI-Powered Dosimetry for Precision Medicine
Shyam M. Srinivas, MD, PhD – UCI Health
Chris Heble – GE HealthCare
This session will cover the integration of advanced digital imaging techniques and AI-driven dosimetry, showcasing their impact on precision medicine. Gain insights into how these technologies are being used to improve diagnostic accuracy and therapeutic efficacy in Theranostics care.
GE HealthCare
3:30 – 5:00 p.m. CT | Rivergate Room
Dosimetry Open House
Connect with MIM Software dosimetry specialists and see how MIM SurePlan MRT can help simplify Theranostics dosimetry.
MIM Software, a GE HealthCare Company
5:30 – 6:30 p.m CT | Room R06-R07
Read with an Expert: Amyloid PET Imaging with Vizamyl™ (Flutemetamol F 18 Injection) for Both Typical and Challenging Patient Cases
Phillip Kuo, MD, PhD – City of Hope National Medical Center
Nearly 7 million Americans are living with Alzheimer’s disease. As the aging population grows and new therapies enter the market, amyloid PET imaging is an increasingly important tool for early and accurate diagnosis. GE HealthCare is pleased to provide an opportunity to learn more from Dr. Phillip Kuo about how Vizamyl’s advanced capabilities can support you in both typical and challenging patient cases.
GE HealthCare
5:30 – 6:30 p.m. CT | Room R02-R03
Unlocking the Future of Healthcare with Molecular Imaging Innovation
Paul Evans, PhD – GE HealthCare
Maheswari Senthil, MD, FACS – University of California, Irvine
Andrew Scott, MBBS, MD, FRACP, FAHMS, FSNMMI – Austin Health and Olivia Newton-John Cancer Research Institute
Ephraim Parent, MD, PhD – Mayo Clinic Florida Department of Radiology
Pooja Advani, MBBS, MD – Mayo Clinic Comprehensive Cancer Center
Adam Schwarz, PhD – GE HealthCare
This scientific symposium offers a cutting-edge perspective on the potential of innovative molecular imaging diagnostics across neurology, cardiology and oncology care areas, with a deeper dive into various oncological settings aimed at improving patient outcomes. Join us and engage with leading experts in Nuclear Medicine and Oncology as they discuss the transformative role of novel PET radiotracers in redefining the future of cancer care through precision diagnostics.
GE HealthCare
Let's Talk
Visit booth 1023 or schedule an in-booth demo to learn how MIM can help standardize your clinical workflow.
